Skip to main content
BioArctic logo

BioArctic — Investor Relations & Filings

Ticker · BIOA ISIN · SE0010323311 LEI · 549300Y0OI2WVUNHLC33 ST Professional, scientific and technical activities
Open in API
Filings indexed 432 across all filing types
Latest filing 2018-06-27 Board/Management Inform…
Country SE Sweden
Listing ST BIOA

About BioArctic

https://www.bioarctic.se/en/

BioArctic is a research-intensive biopharmaceutical company focused on developing disease-modifying treatments, biomarkers, and diagnostics for neurodegenerative diseases. The company's core strategy is based on its proprietary antibody technology, which develops unique treatments that target the misfolded and aggregated proteins considered to be the underlying cause of disorders such as Alzheimer's and Parkinson's disease. Through strategic partnerships with global pharmaceutical companies, BioArctic advances its innovative therapies from research through clinical development and commercialization, aiming to address significant unmet medical needs in neurology.

Recent filings

Filing Released Lang Actions
BioArctic announces changes in the Management Team effective September 1, 2018
Board/Management Information Classification · 1% confidence The document is explicitly titled "BioArctic announces changes in the Management Team effective September 1, 2018." It details personnel changes involving a founder resuming full-time employment and another founder leaving his employment role while remaining on the Board. This content directly aligns with the definition of Board/Management Information.
2018-06-27 English
BioArctic meddelar förändringar i ledningsgruppen per den 1 september 2018
Board/Management Information Classification · 1% confidence The document is titled "Pressmeddelande" (Press Release) and explicitly announces changes in the senior management team ("BioArctic meddelar förändringar i ledningsgruppen"). It details one executive returning to full employment (Lars Lannfelt) and another leaving his employment role while remaining on the board (Pär Gellerfors). This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2018-06-27 Swedish
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I BIOARCTIC (PUBL)
AGM Information Classification · 1% confidence The document is explicitly titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I BIOARCTIC (PUBL)" which translates to 'COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING IN BIOARCTIC (PUBL)'. The text details decisions made at the AGM, including the approval of the annual report, granting discharge to the board, re-election of board members, setting board/auditor fees, and approving guidelines for executive compensation. These are all core topics covered in the minutes or official summary of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The document is short and summarizes the outcomes, fitting the description of AGM materials.
2018-05-15 Swedish
REPORT FROM THE ANNUAL GENERAL MEETING IN BIOARCTIC AB (PUBL)
AGM Information Classification · 1% confidence The document explicitly states it is the "REPORT FROM THE ANNUAL GENERAL MEETING IN BIOARCTIC AB (PUBL)" and details the resolutions adopted regarding the annual report, discharge from liability, election/re-election of board members, approval of fees, appointment of the auditor, and remuneration guidelines. These are all core components of the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the classification should be AGM-R.
2018-05-15 English
BioArctic utvidgar forskningssamarbetet med Uppsala universitet kring ny antikroppsteknologi
Regulatory Filings Classification · 1% confidence The document is titled "Pressmeddelande" (Press Release) and announces a specific corporate event: an expanded research collaboration agreement between BioArctic and Uppsala University regarding antibody technology. It includes a date (May 14, 2018), contact information, and a concluding statement about compliance with EU market abuse regulations. This type of announcement, detailing operational or strategic updates that are not standard financial reports (10-K, IR, ER) or mandatory regulatory filings like insider trades (DIRS) or capital changes (CAP/SHA), fits best under the general category for regulatory announcements or miscellaneous corporate news. Since it is a specific, non-financial operational update, and not a standard financial report, it is classified as a Regulatory Filing (RNS) as the most appropriate general category for such announcements that don't fit the highly specific financial/governance codes. The document length (2995 chars) is short, but it is the primary announcement itself, not an announcement *of* another report, so RPA is less suitable than RNS for this type of specific operational news release.
2018-05-14 Swedish
BioArctic extends the research collaboration with Uppsala University regarding new antibody technology
Regulatory Filings Classification · 1% confidence The document is a press release announcing an extension of a research collaboration agreement between BioArctic and Uppsala University regarding antibody technology for crossing the blood-brain barrier. This announcement concerns a strategic business development and research update, not a mandatory financial filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It is a general corporate announcement. Since there is no specific category for 'Research Collaboration Announcement' or 'Strategic Partnership Update', and it is not a standard regulatory filing like DIRS, DVA, or CAP, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that do not fit the highly specific financial or governance codes provided. The document length is short (3106 chars), but it is the primary content, not an announcement *of* another report.
2018-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.